2,756
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Building a drug development database: challenges in reliable data availability

, , , , &
Pages 74-78 | Received 28 Jan 2016, Accepted 16 Jul 2016, Published online: 24 Aug 2016

Figures & data

Figure 1. IND date availability per year. Notes: IND dates were identified and collected from two primary public sources: the Drugs@FDA database and the Federal Register. The availability of dates varied over time, both by total availability of IND dates year-to-year and availability by source.

Figure 1. IND date availability per year. Notes: IND dates were identified and collected from two primary public sources: the Drugs@FDA database and the Federal Register. The availability of dates varied over time, both by total availability of IND dates year-to-year and availability by source.

Figure 2. IND date availability per data source. Notes: IND dates were identified and collected from two primary public sources: the Drugs@FDA database and the Federal Register. The availability of dates varied over time, both by total availability of IND dates year-to-year and availability by source.

Figure 2. IND date availability per data source. Notes: IND dates were identified and collected from two primary public sources: the Drugs@FDA database and the Federal Register. The availability of dates varied over time, both by total availability of IND dates year-to-year and availability by source.

Table 1. Number of NMEs by date entry and data source.

Table 2. Gaps between multiple dates reported for the same NME.